Reach Us +44 1904 929220
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Luminal Breast Cancer Pre-Treated with Pseudo Therapies

Marcos Melián Sosa*

Medical Oncology Department, Hospital Clinico Universitario De Valencia, Valencia, Spain

*Corresponding Author:
Sosa MM
Medical Oncology Department, Hospital Clinico Universitario De Valencia, Valencia, Spain
Tel: +34961973500
E-mail: [email protected]

Received date: March 13, 2019; Accepted date: April 17, 2019; Published date: April 23, 2019

Citation: Sosa MM (2019) Luminal Breast Cancer Pre-Treated with Pseudo Therapies. Med Case Rep Vol.5 No.2:95.

 
Visit for more related articles at Medical Case Reports

Clinical Image

In October 2017, a 55-year-old postmenopausal woman, who previously has been treated with alternatives cancer treatments, presented at the emergency department for evaluation and treatment.

The patient reported that one year ago, she had felt a big lump in her left breast, and she didn’t consult in the hospital. She was treated with another cancer treatment without evidence of benefit. Progressively, both breasts had become much erythematous, itchy and appearance of cutanides and axillary and supraclavicular lymphadenopathies (Figure 1).

medical-case-reports-Appearance-cutanides

Figure 1: Appearance of cutanides and axillary and supraclavicular lymphadenopathies.

Finally, she was diagnosed of an intraductal carcinoma T4cN3cM1 due to lung metastasis, grade 3 Stage IV, positive estrogen and progesterone receptor positive, Ki 67: 8%, human epidermal growth factor receptor 2 (HER2) negative.

In November 2017, we decided start treatment with Letrozole 2.5 miligrams (mg) per day and Palbociclib 125 mg per day, administered o rally in 4-week cycles (3 weeks of treatment followed by 1 week off). After 2 months of treatment with no adverse events, she presented an excellent clinical response (Figure 2) and continued treatment. In next evaluation Computer Tomography Scan showed decrease of lung metastasis and clinically existed a decreased of breast lesion and lymphadenopathies (Figure 3). At present, the patients continue with Letrozole and Palbociclib with no disease progression.

medical-case-reports-Clinical

Figure 2: Clinical responses.

medical-case-reports-Computer-tomography

Figure 3: Computer tomography scan showed decrease of lung metastasis and clinically existed a decreased of breast lesion and lymphadenopathies.

Select your language of interest to view the total content in your interested language

Viewing options

Post your comment

Share This Article

Flyer image
journal indexing image
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh